SHH and nevoid basal cell carcinoma syndrome: Patient characteristics for the Gorlin cohort (all genetically diagnosed PTCH1 and SUFU associated Gorlin syndrome patients) vs. the Comparative cohort (all DMB/MBEN, SHH+, <3.5y).